Published on 10 Apr 2024 on Insider Monkey via Yahoo Finance
Should You Invest in CONMED (CNMD)?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The Strategy underperformed the benchmark in the quarter. The small-cap growth universe revealed a stark dichotomy despite the positive performance of the benchmark Russell 2000 Growth Index, which returned 7.58% in the first quarter. The Strategy posted gains in 5 of the nine sectors in which it was invested on an absolute basis. Overall stock selection detracted from performance, partially offset by positive sector allocation effects on a relative basis. In addition, please check the fund’s top five holdings to know its best picks in 2024.
ClearBridge Small Cap Growth Strategy featured stocks CONMED Corporation (NYSE:CNMD) in the first quarter 2024 investor letter. Headquartered in Largo, Florida, CONMED Corporation (NYSE:CNMD) is a medical technology company. On April 9, 2024, CONMED Corporation (NYSE:CNMD) stock closed at $80.36 per share. One-month return of CONMED Corporation (NYSE:CNMD) was -8.28%, and its shares lost 27.25% of their value over the last 52 weeks. CONMED Corporation (NYSE:CNMD) has a market capitalization of $2.421 billion.
ClearBridge Small Cap Growth Strategy stated the following regarding CONMED Corporation (NYSE:CNMD) in its first quarter 2024 investor letter: